(NASDAQ: OMIC) Singular Genomics Systems's forecast annual revenue growth rate of -27.86% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.
Singular Genomics Systems's revenue in 2024 is $2,911,000.On average, 1 Wall Street analysts forecast OMIC's revenue for 2024 to be $155,249,970, with the lowest OMIC revenue forecast at $155,249,970, and the highest OMIC revenue forecast at $155,249,970.
In 2025, OMIC is forecast to generate $524,892,755 in revenue, with the lowest revenue forecast at $524,892,755 and the highest revenue forecast at $524,892,755.